PulseAugur
EN
LIVE 16:58:53
中文(ZH) 医疗AI独角兽OpenEvidence再传融资意向,潜在估值升至200亿美元

Medical AI startup OpenEvidence eyes $20B valuation amid funding talks

OpenEvidence, a medical AI startup often referred to as "the ChatGPT for doctors," is reportedly in talks for a new funding round that could value the company at $20 billion. This valuation is driven by the company's strong performance in clinical decision support and medical data analysis. Separately, China's Ministry of Education is emphasizing the strategic importance of its national smart education platform, acknowledging the opportunities and challenges presented by AI in education. AI

IMPACT Potential acceleration of AI adoption in healthcare and education sectors.

RANK_REASON Significant funding round for a prominent AI startup. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Medical AI startup OpenEvidence eyes $20B valuation amid funding talks

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Medical AI unicorn OpenEvidence receives another financing intention, potential valuation rises to $20 billion

    7月18日消息,据报道,有“医生版ChatGPT”之称的医疗人工智能初创公司OpenEvidence正在酝酿新一轮的融资计划。据悉,由于其在临床决策辅助和医学数据解析领域的强劲表现,外部风险投资机构正开出高达200亿美元的潜在估值,积极争取入股份额。